<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical TherapyHelena Lanzafame, Wolfgang P. Fendler, Ken Herrmann et al.|Journal of Nuclear Medicine|2024Cited by 36
Diagnostic Accuracy of<sup>68</sup>Ga-FAPI Versus<sup>18</sup>F-FDG PET in Patients with Various MalignanciesNader Hirmas, Wolfgang P. Fendler, Rainer Hamacher et al.|Journal of Nuclear Medicine|2024Cited by 31
Oncologic Staging with<sup>68</sup>Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than<sup>18</sup>F-FDG PET/CTTristan T. Demmert, Wolfgang P. Fendler, Kelsey L. Pomykala et al.|Journal of Nuclear Medicine|2023Cited by 23
Prognostic Implications of<sup>68</sup>Ga-FAPI-46 PET/CT–Derived Parameters on Overall Survival in Various Types of Solid TumorsMasao Watanabe, Manuel Weber, Wolfgang P. Fendler et al.|Journal of Nuclear Medicine|2024Cited by 18
Head-to-head comparison of 68 Ga-FAPI-46 PET/CT, 18F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumorsMasao Watanabe, Manuel Weber, Wolfgang P. Fendler et al.|Annals of Nuclear Medicine|2024Cited by 15